SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-029657
Filing Date
2022-10-27
Accepted
2022-10-27 06:02:42
Documents
19
Period of Report
2022-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56083
2 ex4-1.htm EX-4.1 91678
3 ex4-2.htm EX-4.2 91740
4 ex10-1.htm EX-10.1 27629
5 ex10-2.htm EX-10.2 30274
6 ex10-3.htm EX-10.3 26277
7 ex4-1_001.jpg GRAPHIC 2857
8 ex4-2_001.jpg GRAPHIC 2124
  Complete submission text file 0001493152-22-029657.txt   557358

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgs-20221023.xsd EX-101.SCH 3230
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgs-20221023_lab.xml EX-101.LAB 34916
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgs-20221023_pre.xml EX-101.PRE 22791
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3619
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 221334730
SIC: 2834 Pharmaceutical Preparations